Todos Med Ltd (EM) TOMDF

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer’s influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and T...

EXPM:TOMDF - Post by User

Todos Med Ltd (EM)

<< Previous

Bullboard Posts

Next >>

(2)
•••

Post by Red~Oneon Aug 22, 2022 10:55am

114 Views

Post# 34911302

Todos launches monkeypox PCR test in US

Todos Medical ( OTCQB:TOMDF ) said its laboratory Provista Diagnostics completed CLIA validation and commercially launched lesion and saliva-based monkeypox PCR testing in the U.S.
Provista will collect saliva samples matched with lesion swabs from confirmed MonkeyPox cases before launching a standalone laboratory-developed test (LDT) targeted at identifying monkeypox in the pre-symptomatic stage, the company said in an Aug. 22 press release.
Todos noted that Provista currently has PCR automation capacity to run 25K PCR tests per day with ongoing efforts to increase the capacity to 50K tests per day.
The Israeli company added that it is also preparing validation plans for an IgM/IgG blood-based monkeypox LDT to confirm recent infection as part of a planned MonkeyPox Panel.